Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Predict S.P.A. Class B ( (IT:PRE) ) has provided an update.
Predict S.p.A.’s board has proposed that shareholders renew authorization for a share buyback program, replacing the unused portion of the mandate that is nearing expiry. The plan would allow the company to purchase up to €700,000 of its own shares, capped at 20% of share capital, over an 18‑month period under defined price and volume limits on Euronext Growth Milan.
The renewed authorization is designed to support share liquidity, fund employee and director incentive schemes, and provide stock to use as consideration in potential extraordinary transactions, including M&A and convertible instruments. The board is also seeking unlimited duration for the disposal of treasury shares to maximize strategic flexibility, noting that Predict currently holds 48,000 treasury shares, equal to 0.618% of its share capital.
The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.45 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.
More about Predict S.P.A. Class B
Predict S.p.A. is an innovative Italian med-tech SME focused on in vivo diagnostics, distributing ultrasound and radiological equipment while developing advanced breath analysis and digital healthcare technologies. The company is listed on Euronext Growth Milan and targets improved diagnostic capabilities through both hardware distribution and proprietary innovation in digital health tools.
Average Trading Volume: 26,285
Technical Sentiment Signal: Sell
Current Market Cap: €5.75M
Find detailed analytics on PRE stock on TipRanks’ Stock Analysis page.

